Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Christopoulos

Showing results (71-80 of 331) with videos related to

Pageof 34
Sort By:
Nature Reviews. Molecular Cell Biology|August 15, 2018
Mechanisms of signalling and biased agonism in G protein-coupled receptorsDenise Wootten, Arthur Christopoulos, Maria Marti-Solano, et al.
Regulatory Peptides|September 22, 2007
The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptorsMadhara Udawela, George Christopoulos, Maria Morfis, et al.
Scientific Reports|November 17, 2018
Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A<sub>1</sub> ReceptorYinglong Miao, Apurba Bhattarai, Anh T N Nguyen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2009
Effect of the calcimimetic R-568 [3-(2-chlorophenyl)-N-((1R)-1-(3-methoxyphenyl)ethyl)-1-propanamine] on correcting inactivating mutations in the human calcium-sensing receptorJenny Ying Lin Lu, Yuhua Yang, Gilles Gnacadja, et al.
Molecular Pharmacology|March 15, 2006
Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptorsMadhara Udawela, George Christopoulos, Nanda Tilakaratne, et al.
ACS Chemical Neuroscience|September 5, 2014
Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptorBriana J Davie, Patrick M Sexton, Ben Capuano, et al.
Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs as drug targetsPatrick M Sexton, David R Poyner, John Simms, et al.
Biochemical Society Transactions|April 13, 2016
The complexity of signalling mediated by the glucagon-like peptide-1 receptorMadeleine M Fletcher, Michelle L Halls, Arthur Christopoulos, et al.
Molecular Pharmacology|December 1, 2012
Allosteric modulation of a chemogenetically modified G protein-coupled receptorAlaa Abdul-Ridha, J Robert Lane, Patrick M Sexton, et al.
Progress in Molecular Biology and Translational Science|August 10, 2010
Receptor activity modifying proteins and their potential as drug targetsDenise L Wootten, John Simms, Debbie L Hay, et al.
Pageof 34

Showing results (71-80 of 331) with videos related to

Sort By:
Pageof 34
Nature Reviews. Molecular Cell Biology|August 15, 2018
Mechanisms of signalling and biased agonism in G protein-coupled receptorsDenise Wootten, Arthur Christopoulos, Maria Marti-Solano, et al.
Regulatory Peptides|September 22, 2007
The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptorsMadhara Udawela, George Christopoulos, Maria Morfis, et al.
Scientific Reports|November 17, 2018
Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A<sub>1</sub> ReceptorYinglong Miao, Apurba Bhattarai, Anh T N Nguyen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2009
Effect of the calcimimetic R-568 [3-(2-chlorophenyl)-N-((1R)-1-(3-methoxyphenyl)ethyl)-1-propanamine] on correcting inactivating mutations in the human calcium-sensing receptorJenny Ying Lin Lu, Yuhua Yang, Gilles Gnacadja, et al.
Molecular Pharmacology|March 15, 2006
Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptorsMadhara Udawela, George Christopoulos, Nanda Tilakaratne, et al.
ACS Chemical Neuroscience|September 5, 2014
Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptorBriana J Davie, Patrick M Sexton, Ben Capuano, et al.
Advances in Experimental Medicine and Biology|March 22, 2012
RAMPs as drug targetsPatrick M Sexton, David R Poyner, John Simms, et al.
Biochemical Society Transactions|April 13, 2016
The complexity of signalling mediated by the glucagon-like peptide-1 receptorMadeleine M Fletcher, Michelle L Halls, Arthur Christopoulos, et al.
Molecular Pharmacology|December 1, 2012
Allosteric modulation of a chemogenetically modified G protein-coupled receptorAlaa Abdul-Ridha, J Robert Lane, Patrick M Sexton, et al.
Progress in Molecular Biology and Translational Science|August 10, 2010
Receptor activity modifying proteins and their potential as drug targetsDenise L Wootten, John Simms, Debbie L Hay, et al.
Pageof 34